During the past decade, MENSINGDERMA Research GmbH conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 9 clinical trials were completed, i.e. on average, 56.3% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 9 clinical trials were completed. i.e. 81.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "MENSINGDERMA Research GmbH" #1 sponsor was "Pfizer" with 5 trials, followed by "Janssen Research & Development, LLC" with 4 trials sponsored, "AKARI Therapeutics" with 1 trials sponsored, "Aristea Therapeutics, Inc." with 1 trials sponsored and "Asana BioSciences" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

According to Clinical.Site data, the most researched conditions in "MENSINGDERMA Research GmbH" are "Atopic Dermatitis" (5 trials), "Psoriasis" (4 trials), "Dermatitis, Atopic" (3 trials), "Plaque Psoriasis" (2 trials) and "Bullous Pemphigoid" (1 trials). Many other conditions were trialed in "MENSINGDERMA Research GmbH" in a lesser frequency.

Most popular intervention types in "MENSINGDERMA Research GmbH" are "Drug" (16 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Guselkumab" (2 trials), "JNJ-77242113" (2 trials), "PF-06700841" (2 trials) and "Vehicle (Placebo)" (2 trials). Other intervention names were less common.

The vast majority of trials in "MENSINGDERMA Research GmbH" are 16 trials for "All" genders.

Currently, there are NaN active trials in "MENSINGDERMA Research GmbH". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in MENSINGDERMA Research GmbH, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in MENSINGDERMA Research GmbH, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".